These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway. Weis M; Cooke JP Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):567-75. PubMed ID: 12649081 [TBL] [Abstract][Full Text] [Related]
6. Parsing the effects of nitric oxide, S-nitrosothiols, and peroxynitrite on inducible nitric oxide synthase-dependent cardiac myocyte apoptosis. Beckman JS Circ Res; 1999 Oct; 85(9):870-1. PubMed ID: 10532956 [No Abstract] [Full Text] [Related]
7. The role of nitric oxide in heart failure. Arstall MA; Kelly RA Coron Artery Dis; 1999 Jul; 10(5):301-8. PubMed ID: 10421969 [No Abstract] [Full Text] [Related]
8. Nitric oxide and the respiratory system in health and disease. al-Ali MK; Howarth PH Respir Med; 1998 May; 92(5):701-15. PubMed ID: 9713628 [No Abstract] [Full Text] [Related]
9. Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection. Mannon RB; Roberts K; Ruiz P; Laubach V; Coffman TM J Heart Lung Transplant; 1999 Sep; 18(9):819-27. PubMed ID: 10528743 [TBL] [Abstract][Full Text] [Related]
10. Nitric oxide in liver transplantation: pathobiology and clinical implications. Shah V; Kamath PS Liver Transpl; 2003 Jan; 9(1):1-11. PubMed ID: 12514766 [TBL] [Abstract][Full Text] [Related]
11. Acute cardiac allograft rejection in nitric oxide synthase-2(-/-) and nitric oxide synthase-2(+/+) mice: effects of cellular chimeras on myocardial inflammation and cardiomyocyte damage and apoptosis. Szabolcs MJ; Ma N; Athan E; Zhong J; Ming M; Sciacca RR; Husemann J; Albala A; Cannon PJ Circulation; 2001 May; 103(20):2514-20. PubMed ID: 11369694 [TBL] [Abstract][Full Text] [Related]
12. Time course and cellular localization of inducible nitric oxide synthases expression during cardiac allograft rejection. Worrall NK; Misko TP; Botney MD; Sullivan PM; Hui JJ; Suau GM; Manning PT; Ferguson TB Ann Thorac Surg; 1999 Mar; 67(3):716-22. PubMed ID: 10215216 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Szabolcs MJ; Ravalli S; Minanov O; Sciacca RR; Michler RE; Cannon PJ Transplantation; 1998 Mar; 65(6):804-12. PubMed ID: 9539092 [TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of nitric oxide production during cardiac allograft rejection causes a small increase in graft survival. Winlaw DS; Schyvens CG; Smythe GA; Du ZY; Rainer SP; Lord RS; Spratt PM; Macdonald PS Transplantation; 1995 Jul; 60(1):77-82. PubMed ID: 7624947 [TBL] [Abstract][Full Text] [Related]
15. N omega -monomethyl-L-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft rejection. Bastian NR; Xu S; Shao XL; Shelby J; Granger DL; Hibbs JB Biochim Biophys Acta; 1994 May; 1226(2):225-31. PubMed ID: 7515690 [TBL] [Abstract][Full Text] [Related]
16. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Ii M; Nishimura H; Iwakura A; Wecker A; Eaton E; Asahara T; Losordo DW Circulation; 2005 Mar; 111(9):1114-20. PubMed ID: 15723985 [TBL] [Abstract][Full Text] [Related]
17. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide. Koglin J Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787 [TBL] [Abstract][Full Text] [Related]